subscribeSubscribe
U.S. subpoenas Endo for information on opioid painkillers

U.S. subpoenas Endo for information on opioid painkillers
Nate Raymond REUTERS
11 Jan 2018
Share Share
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc

Pomerantz Law Firm Investigates Claims On Behalf of Investors of Endo International plc
PR NEWSWIRE
23 Jun 2017
Share Share
US FDA requests Endo Pharma remove Opana ER for risks related to abuse

US FDA requests Endo Pharma remove Opana ER for risks related to abuse
BIOSPECTRUM
12 Jun 2017
Share Share
FDA Asks Endo Pharma to Stop Selling Opana ER Amid Opioid Crisis

FDA Asks Endo Pharma to Stop Selling Opana ER Amid Opioid Crisis
Alex Keown BIOSPACE
10 Jun 2017
Share Share
Endo Statement On FDA Advisory Committees` Vote Related To OPANA® ER

Endo Statement On FDA Advisory Committees` Vote Related To OPANA® ER
PR NEWSWIRE
14 Mar 2017
Share Share
FDA Panel To Re-Examine Opana ER

FDA Panel To Re-Examine Opana ER
SEEKING ALPHA
11 Mar 2017
Share Share
Endo Announces Agreement to Resolve FTC Investigation and Litigation

Endo Announces Agreement to Resolve FTC Investigation and Litigation
PR NEWSWIRE
23 Jan 2017
Share Share
Grunenthal says anti-crush tech Endo uses for Opana ER helps prevent abuse

Grunenthal says anti-crush tech Endo uses for Opana ER helps prevent abuse
Gareth MacDonald+ IN PHARMATECHNOLOGIST
25 Aug 2016
Share Share
Endo withdraws abuse-deterrent labelling for Opana ER

Endo withdraws abuse-deterrent labelling for Opana ER
Selina McKee PHARMATIMES
15 Aug 2016
Share Share
Aurolife`s Generic Oxymorphone Hydrochloride approved in US for the relief of moderate to severe acute pain

Aurolife`s Generic Oxymorphone Hydrochloride approved in US for the relief of moderate to severe acute pain
FDA
26 Apr 2016
Share Share